Multimodality vascular imaging in CKD: Divergence of risk between measured parameters

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1004-1012

  Petchey, William G ^a,b   Hawley, Carmel M ^a,b   Johnson, David W ^a,b   Haluska, Brian A ^a   Watkins, Trevor W ^b   Isbel, Nicole M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Calcification; Chronic kidney failure; Uraemia; Vasodilation

Indexed keywords

CALCITRIOL;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RISK ASSESSMENT;

EID: 84861131702     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr397     Document Type: Article

References (53)

1. Kaisar MO, Isbel NM, Johnson DW. Cardiovascular disease in patients with chronic kidney disease. A clinical review. Minerva Urol Nefrol 2007; 59: 281-297
2. Kennedy R, Case C, Fathi R et al. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med 2001; 110: 198-204
3. Rakhit DJ, Marwick TH, Armstrong KA et al. Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart 2006; 92: 1402-1408
4. Kaisar MO, Isbel NM, Johnson DW. Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Rev Recent Clin Trials 2008; 3: 79-88
5. Johnson DW, Craven AM, Isbel NM. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int 2007; 11: 1-14
6. The Sharp Collaborative Group. Should we reduce LDL cholesterol in patients with chronic kidney disease? The results of the Study of Heart And Renal Protection (SHARP). J Am Soc Nephrol 2010; 21: 2B
7. Drueke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol 2010; 6: 723-735
8. Goodman WG, London G, Amann K et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579.
9. Rubin MF, Rosas SE, Chirinos JA et al. Surrogate markers of cardiovascular disease in CKD: what's under the hood? Am J Kidney Dis 2011; 57: 488-497
10. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
11. London GM, Guerin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25- hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18: 613-620
12. Toussaint ND, Lau KK, Strauss BJ et al. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 586-593
13. D'Agostino RB Sr, Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753
14. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
15. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-S201
16. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-S266
18. Levey AS, de Jong PE, Coresh J et al. The. definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2010; 80: 17-28
19. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
20. Pugliese G, Solini A, Bonora E et al. (May 6, 2011). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis 2011, Pubmed ID 21612781
21. Fathi R, Marwick TH. Noninvasive tests of vascular function and structure: why and how to perform them. Am. Heart J. 2001; 141: 694-703
22. Fathi R, Haluska B, Isbel N et al. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004; 43: 616-623
23. Haluska B, Sutherland A, Case C et al. Automated edge-detection technique for measurement of brachial artery reactivity: a comparison of concordance with manual measurements. Ultrasound Med Biol 2001; 27: 1285-1289
24. Kauppila LI, Polak JF, Cupples LA et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132: 245-250
25. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605
26. London GM, Blacher J, Pannier B et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438
27. Fathi R, Isbel N, Short L et al. The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. Am J Kidney Dis 2004; 43: 45-52
28. Goldsmith D. The case against routine screening for vascular calcification in chronic kidney disease. Semin Dial 2010; 23: 280-282
29. Townsend RR, Wimmer NJ, Chirinos JA et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 2010; 23: 282-289
30. Zoungas S, Cameron JD, Kerr PG et al. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis. 2007; 50: 622-630
31. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
32. Konings CJ, Dammers R, Rensma PL et al. Arterial wall properties in patients with renal failure. Am J Kidney Dis 2002; 39: 1206-1212
33. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 76: S1-S130
34. Briese S, Wiesner S, Will JC et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006; 21: 1906-1914
35. Jean G, Bresson E, Terrat JC et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 2009; 24: 948-955
36. Hanada S, Ando R, Naito S et al. Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 2010; 25: 1888-1895
37. Garcia-Canton C, Bosch E, Ramirez A et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 2011; 26: 2250-2256
38. Doherty TM, Tang W, Dascalos S et al. Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 1997; 96: 1477-1481
39. Watson KE, Abrolat ML, Malone LL et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755-1760
40. Fraser JD, Price PA. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells. Calcif Tissue Int 1990; 46: 270-279
41. Drissi H, Pouliot A, Koolloos C et al. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res 2002; 274: 323-333
42. Bellows CG, Reimers SM, Heersche JN. Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1,25 dihydroxyvitamin D3. Cell Tissue Res 1999; 297: 249-259
43. Matias PJ, Ferreira C, Jorge C et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618
44. Razzaque MS. The. dualistic role of vitamin D in vascular calcifications. Kidney Int 2011; 79: 708-714
45. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494-501
46. Briet M, Bozec E, Laurent S et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006; 69: 350-357
47. Tetzner F, Scholze A, Wittstock A et al. Impaired vascular reactivity in patients with chronic kidney disease. Am J Nephrol 2008; 28: 218-223
48. Matsuda N, Takei T, Fujiu A et al. Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb 2009; 16: 57-62
49. Temmar M, Liabeuf S, Renard C et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28: 163-169
50. Guerin AP, Pannier B, Metivier F et al. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 635-641
51. Pannier B, Guérin AP, Marchais SJ et al. Arterial structure and function in end-stage renal disease. Artery Res 2007; 1: 79-88
52. Yilmaz MI, Stenvinkel P, Sonmez A et al. (March 4, 2011) Vascular. health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant 2011, Pubmed ID 21378154
53. Diaz-Buxo JA, Woods HF. Protecting the endothelium: a new focus for management of chronic kidney disease. Hemodial Int 2006; 10: 42-48